Loading clinical trials...
Loading clinical trials...
An Adaptive Randomised Placebo Controlled Phase II Trial of Antivirals for COVID-19 Infection
Conditions
Interventions
Favipiravir
Locations
1
Australia
Alfred Health
Melbourne, Victoria, Australia
Start Date
July 30, 2020
Primary Completion Date
November 1, 2021
Completion Date
December 1, 2021
Last Updated
October 7, 2021
NCT06082518
NCT07221162
NCT06721949
NCT06631287
NCT06679140
NCT06417762
Lead Sponsor
Bayside Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions